Shire PLC (SHPG.OQ)
16 Feb 2018
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|58||2014||Independent Non-Executive Chairman of the Board|
|59||2013||Chief Executive Officer, Executive Director|
|2018||Interim Chief Financial Officer|
|2017||Chief Human Resource Officer|
|54||2018||Executive Vice President - Head of Research and Development, Chief Scientific Officer|
- BRIEF-Shire Announces FDA Acceptance Of sBLA For Cinryze For Pediatric Hereditary Angioedema Use
- UPDATE 1-UK Stocks-Factors to watch on Feb 15
- UK Stocks-Factors to watch on Feb 15
- UPDATE 2-Shire sees slowdown in earnings growth as generic rivals bite
- BRIEF-Shire says too early to see impact Of Roche competitor Hemlibra
- Now is the perfect time to buy these 3 healthcare stocks!
- 2 'must-have' healthcare stocks after today's updates?
- Simply the best growth stocks in the FTSE 100?
- Are these 3 Brexit beaters set to fly after today's news?
- Are these 3 stocks due for a serious price correction?
- Should you buy Shire plc, Marks and Spencer Group plc and Amec Foster Wheeler plc following today's news?